A Study of LY2409021 in Patients With Type 2 Diabetes
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 263 participants.
Also called NCT01241448
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 263 participants
- Sponsor
- Registry
-
NCT01241448
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Germany, Italy, Puerto Rico, Romania, Slovakia, Spain
- Registry status
- Completed
Technical summary
Registry record NCT01241448. Randomized; double masking; primary purpose treatment. Start 2011-01 (registry gives no type); primary completion 2012-02 (actual). Results posted on 2018-04-24.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of LY2409021 in Patients With Type 2 Diabetes
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- LY2409021
- Intervention (Drug)
- Placebo
- Lead sponsor
- Eli Lilly and Company
Record details
- Record id
cardio:ct-nct01241448- Content hash
44d20336f3eb45ac187c684e55c3b36c72a12e23520d2a1f6e099470506f9218